Isomer Distribution of Perfluorocarboxylates in Human Blood: Potential Correlation to Source

Abstract

Detection of perfluorocarboxylate anions (PFCAs), such as perfluorooctanoate (C7F15COO-, PFOA), at ng/g levels in human tissues has engendered public scrutiny of industrial fluorochemicals. Routes of PFCA exposure for the general human population are likely diverse given direct (industrially produced) and indirect (production from precursor organofluorines) sources. Major industrial production of organofluorines, including PFCAs, stems from either electrochemical fluorination (ECF) or telomerization. ECF products are a mixture of structural isomers (linear and branched perfluoroalkyls) and telomerization products are assumed to have one perfluorocarbon arrangement, typically linear. The objective of this research was to investigate structural isomer patterns of PFCAs in human blood. Volatile derivatives of PFCAs in human blood were analyzed by GC-(NCI)-MS for quantitation and isomers. PFOA was the dominant PFCA (mean 4.4 ng/g). Blood serum isomer profiles consisted of predominantly (mean approximately 98%) the linear isomer for each PFCA (C8-C11). There were similarities in branched isomer patterns of an ECF PFOA standard with both PFOA and PFNA in blood. Direct exposure to ECF PFOA, which has a legacy of production for uses in fluoropolymer industries, is postulated to be a source of the observed branched isomer pattern. Predominance of linear PFCA isomers and the [even PFCA] > [odd PFCA] concentration trend in blood is suggestive of additional input from a strictly linear perfluoroalkyl source.